WHO ICTRP trial
Efficacy and Safety Study of Ruxolitinib Cream Followed by an Extension Period…
EUCTR2019-000846-37-FR · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2019-000846-37-FR |
|---|---|
| Public title | Efficacy and Safety Study of Ruxolitinib Cream Followed by an Extension Period in Participants with Vitiligo |
| Scientific title | A Phase 3, Double-Blind, Randomized, Vehicle-Controlled, Efficacy and Safety Study of Ruxolitinib Cream Followed by an Extension Period in Participants With Vitiligo - Topical Ruxolitinib Evaluation in Vitiligo Study 1 (TRuE-V1) |
| Primary sponsor | Incyte Corporation |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): no Therapeutic exploratory (Phase II): no Therapeutic confirmatory - (Phase III): yes Therapeutic use (Phase IV): no |
| Countries | United States;France;Canada;Spain;Poland;Bulgaria;Netherlands;Germany;United Kingdom;Italy |
| Conditions | Vitiligo MedDRA version: 21.1 Level: PT Classification code 10047642 Term: Vitiligo System Organ Class: 10040785 - Skin and subcutaneous tissue disorders ;Therapeutic area: Diseases [C] - Skin and Connective Tissue Diseases [C17] |
| Interventions | Product Code: INCB018424 PHOSPHATE CREAM 1.5% Pharmaceutical Form: Cream INN or Proposed INN: ruxolitinib (phosphate) CAS Number: 1092939-17-7 Current Sponsor code: INCB018424 phosphate Other descriptive name: RUXOLITINIB PHOSPHATE… |
| Registration date | Dec 13, 2019 |
| Target size | 300 |
| Secondary IDs | INCB18424-306 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- Yes Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: